Prevalence of hypertensive disorders in pregnancy in China: A systematic review and meta-analysis
- PMID: 33626437
- DOI: 10.1016/j.preghy.2021.02.001
Prevalence of hypertensive disorders in pregnancy in China: A systematic review and meta-analysis
Abstract
Hypertensive disorders in pregnancy (HDP) are associated with various maternal and fetal adverse outcomes and become an increasingly significant threat to Chinese pregnant women. Yet, the prevalence of HDP in China is not clear. We conducted this meta-analysis to estimate the prevalence of HDP and specific subtypes in China. We searched PubMed, Embase, Web of Science, CNKI, Wangfang, and CMB for studies on prevalence of HDP and specific subtypes, published from 1990 to Jan 21, 2020, without language restrictions. We included all studies reported the prevalence of HDP and specific subtypes in Chinese pregnant women. We excluded qualitative studies, case reports, reviews, conference presentations, and studies only provided abstracts. We using a standard self-developed form to extract information from eligible studies. We did meta-analyses by random-effect models and estimated the pooled prevalence of HDP and specific subtypes. In order to explore potential sources of heterogeneity and subgroup effects, we did and meta-regression and subgroup analyses by pre-specified covariates. This study is registered with PROSPERO, number CRD42020166001. We initially identified 4179 records, of which 92 studies with 1,377,448 participants were eligible in the final systematic review and meta-analyses. The pooled prevalence (95% CI) of HDP, gestational hypertension, preeclampsia, mild preeclampsia, severe preeclampsia, eclampsia, chronic hypertension, and chronic hypertension with superimposed preeclampsia were 7.30% (6.60%-8.00%), 3.30% (2.90%-3.70%), 4.50% (4.00%-5.00%), 2.00% (1.70%-2.30%), 2.60% (2.10%-3.00%), 0.11% (0.08%-0.15%), 0.60% (0.30%-0.90%), and 0.60% (0.40%-0.80%), respectively. No publication bias was identified, although heterogeneity was high (I2 statistics: 92.0%-99.3%). High prevalence of HDP and the subtypes frequently reported in Western and Northern China. Pregnant women who were aged 35 years and above had high prevalence of HDP and subtypes; women who were overweight or obese had high prevalence of HDP, gestational hypertension and preeclampsia. The prevalence of HDP and the subtypes vary in different areas in China. Given to increasingly prevalent of the risk factors, such as overweight, obesity, and advance maternal age, strategies to prevent and manage HDP need to be improved, especially for women living in Western and Northern China.
Keywords: Chinese women, meta-analysis; Hypertensive disorders in pregnancy; Prevalence.
Copyright © 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.
Similar articles
-
The burden of hypertensive disorders of pregnancy in Africa: A systematic review and meta-analysis.J Clin Hypertens (Greenwich). 2019 Apr;21(4):479-488. doi: 10.1111/jch.13514. Epub 2019 Mar 7. J Clin Hypertens (Greenwich). 2019. PMID: 30848083 Free PMC article.
-
The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes.PLoS One. 2014 Jun 17;9(6):e100180. doi: 10.1371/journal.pone.0100180. eCollection 2014. PLoS One. 2014. PMID: 24937406 Free PMC article.
-
Characteristics and fetal outcomes of pregnant women with hypertensive disorders in China: a 9-year national hospital-based cohort study.BMC Pregnancy Childbirth. 2022 Dec 9;22(1):924. doi: 10.1186/s12884-022-05260-3. BMC Pregnancy Childbirth. 2022. PMID: 36482386 Free PMC article.
-
Hypertensive disorders of pregnancy and the risk of chronic kidney disease: A Swedish registry-based cohort study.PLoS Med. 2020 Aug 14;17(8):e1003255. doi: 10.1371/journal.pmed.1003255. eCollection 2020 Aug. PLoS Med. 2020. PMID: 32797043 Free PMC article.
-
Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials.Ultrasound Obstet Gynecol. 2018 Dec;52(6):706-714. doi: 10.1002/uog.19084. Epub 2018 Nov 1. Ultrasound Obstet Gynecol. 2018. PMID: 29749110
Cited by
-
Dynamic risk prediction models for different subtypes of hypertensive disorders in pregnancy.Front Surg. 2022 Oct 26;9:1005974. doi: 10.3389/fsurg.2022.1005974. eCollection 2022. Front Surg. 2022. PMID: 36386527 Free PMC article.
-
Burden of multiple high-risk factors in pregnancy before and after the universal two-child policy in Chinese women: An observational study.J Glob Health. 2024 Jul 19;14:04134. doi: 10.7189/jogh.14.04134. J Glob Health. 2024. PMID: 39024620 Free PMC article.
-
Association between plasma growth differentiation factor 15 levels and pre-eclampsia in China.Chronic Dis Transl Med. 2024 May 12;10(2):140-145. doi: 10.1002/cdt3.126. eCollection 2024 Jun. Chronic Dis Transl Med. 2024. PMID: 38872765 Free PMC article.
-
Effects of Maternal Pre-Pregnancy BMI and Gestational Weight Gain on the Development of Preeclampsia and Its Phenotypes: A Prospective Cohort Study in China.J Clin Med. 2022 Sep 21;11(19):5521. doi: 10.3390/jcm11195521. J Clin Med. 2022. PMID: 36233388 Free PMC article.
-
Associations between maternal complications during pregnancy and childhood asthma: a retrospective cohort study.ERJ Open Res. 2023 Apr 11;9(2):00548-2022. doi: 10.1183/23120541.00548-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37057092 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical